To see if you qualify for this type of weight loss medication, add the pill to your cart and follow the prompt to connect with a Musely medical provider
Tests in obese mice indicated the triple agonist was more powerful than dual agonists in correcting obesity and diabetes (Finan, Yang, Ottaway)
Yes, GLP-1 medications are now FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related health condition, independent of a diabetes diagnosis
For optimal results, complement tirzepatide with a healthy diet, regular exercise, sufficient sleep, and constant provider check-ins
B 6.8 Reassess glycemic targets over time based on the criteria in older adults A1C and Microvascular Complications Hyperglycemia defines diabetes, and glycemic control is fundamental to diabetes management
Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line